Full name
CLINICAL TRIALS SOLUTIONS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
CLINICAL TRIALS SOLUTIONS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
PL. DWORCOWY 4, 33-100 TARNÓW
TAX ID9930666092
Rate company:
CLINICAL TRIALS SOLUTIONS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9930666092
KRS0000712654
Share capital23,500.00 zł
address
PL. DWORCOWY 4, 33-100 TARNÓW
Website
www.ctsolutions.euCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9930666092
REGON
369371928
KRS
0000712654
Legal form
limited liability company
Register Address
PL. DWORCOWY 4, 33-100 TARNÓW
Date of registration in KRS
2018-01-30
Date of commencement of economic activity
2018-01-30
Act signature
KR.XII NS-REJ.KRS/23101/24/743
Website
WWW.CTSOLUTIONS.EU
Pkd codes
63.11.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
46.51.Z - Wholesale trade
58.29.Z - Publishing of other software
62.01.Z - Activities related to programming, IT consulting, and related activities
62.02.Z - Activities related to programming, IT consulting, and related activities
62.03.Z - Activities related to programming, IT consulting, and related activities
63.12.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
Payer VAT status
Active
Vat list bank account(s)
PL78 1050 1722 1000 0090 8033 9550 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0,3 | 0,1 | 0,8 | 755,9 |
EBITDA | 0,4 | 0,2 | 1,1 | 555,3 |
Short time liabilities | 1,2 | 0,8 | 0,5 | -33,1 |
Equity capital | 1,7 | 1,8 | 2,6 | 39,7 |
Operating profit (EBIT) | 0,4 | 0,2 | 0,8 | 420,8 |
Assets | 3,3 | 3,3 | 3,6 | 9 |
Net profit (loss) | 0,2 | 0,1 | 0,7 | 790,3 |
Cash | 0,8 | 0,1 | 0,1 | -48,6 |
Net income from sale | 1,9 | 1,2 | 1,8 | 54,5 |
Liabilities and provisions for liabilities | 1,5 | 1,5 | 1,1 | -28,7 |
Working assets | 1,2 | 3,3 | 1,1 | -67,4 |
Depreciation | 0 | 0 | 0,2 | 22 728,4 |
% | % | % | p.p. | |
Profitability of capital | 14,2 | 4,5 | 28,4 | 23,9 |
Equity capital to total assets | 53,7 | 55,2 | 70,7 | 15,5 |
Gross profit margin | 15 | 7,9 | 43,9 | 36 |
EBITDA Margin | 19,4 | 13,7 | 58,1 | 44,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 228 | 250 | 108 | -142 |
Current financial liquidity indicator | 0.9939813017845154 | 4.1092400550842285 | 2.0003645420074463 | -2,1 |
Net dept to EBITDA | 1.7462115287780762 | 7.53852653503418 | 0.7906423211097717 | -6,7 |
Financial statements
01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
MAJERNET MARCIN MAJERANEK
CZĘSTOCHOWA
BRIGHTCODE RAFAŁ GAŁKA
BĘDZIN
MAREK GĘBOREK SOFTRANS
Zabrze
PROGRESSIVE MEDIA Sp. z o.o.
Zakopane
"PERITUS-ACT" Mateusz Marzec
Chorzów